What Direct Bilirubin Tests For
Direct bilirubin (also called conjugated bilirubin) measures the water-soluble form of bilirubin that has been processed by the liver through binding with glucuronic acid, and it is used to screen for cholestasis and biliary obstruction, particularly biliary atresia in infants. 1
Understanding the Test
Direct-reacting bilirubin and conjugated bilirubin are often used interchangeably in clinical practice, though they are technically different. Direct-reacting bilirubin is the fraction that reacts directly with diazotized sulfanilic acid without an accelerating agent, while conjugated bilirubin specifically refers to bilirubin bound to glucuronic acid in the liver. For clinical purposes, these terms can be used interchangeably. 1
Clinical Significance and Abnormal Values
The key threshold to remember: if total serum bilirubin (TSB) is ≤5 mg/dL (85 μmol/L), a direct or conjugated bilirubin >1.0 mg/dL is considered abnormal. 1
When to Measure Direct Bilirubin:
- Sick infants or those jaundiced at or beyond 3 weeks of age should have total and direct/conjugated bilirubin measured to identify cholestasis 1
- Infants receiving phototherapy or whose TSB is rising rapidly and unexplained by history and physical examination 1
Primary Screening Application: Biliary Atresia
Direct bilirubin is particularly valuable for detecting biliary atresia (BA), a critical condition requiring early intervention:
- For infants aged 3-60 days: Direct bilirubin ≥1.0 mg/dL has 100% sensitivity for biliary atresia detection with specificity of 77.3% 2
- For newborns <3 days old: Direct bilirubin >0.45 mg/dL provides 100% sensitivity, though specificity is lower at 15.4% 2
- In one study of 35 infants with BA who had newborn direct/conjugated bilirubin measurements, all had elevated concentrations (100% sensitivity) 3
Important Caveat:
Laboratory measurement of direct bilirubin is not precise, and values can vary widely between laboratories. 1 This technical limitation must be considered when interpreting results, though the clinical utility for detecting cholestatic conditions like biliary atresia remains high.
Clinical Context
Direct bilirubin elevation indicates conjugated hyperbilirubinemia, which suggests:
- Hepatic dysfunction in bilirubin excretion
- Biliary obstruction (including biliary atresia)
- Cholestatic liver disease
This distinguishes it from unconjugated (indirect) hyperbilirubinemia, which is the common physiologic jaundice seen in most newborns and relates to bilirubin production and conjugation capacity rather than excretion problems.